scholarly journals TCT-188: Comparison of 4 Years Efficacy and Durability of Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent Deployment in Patients with Very Long Coronary Lesions: Multicenter Registry in Asia

2010 ◽  
Vol 56 (13) ◽  
pp. B44
Keyword(s):  
Stent Deployment ◽  
Coronary Lesions ◽  
Sirolimus Eluting Stent ◽  
Multicenter Registry

Abstract 5992: Comparison of 4 Years Efficacy and Durability of Sirolimus-Eluting Stent and Paclitaxel- Eluting Stent Deployment in Patients with Very Long Coronary Lesions: Multicenter Registry in Asia

Circulation ◽  
2008 ◽  
Vol 118 (suppl_18) ◽  
Author(s):  
Sunao Nakamura ◽  
Hisao Ogawa ◽  
Jang-Ho Bae ◽  
Yeo Hans Cahyadi ◽  
Wasan Udayachalerm ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Stent Thrombosis ◽  
Late Stent Thrombosis ◽  
Cardiac Events ◽  
Stent Deployment ◽  
Very Late Stent Thrombosis ◽  
Coronary Lesion ◽  
Coronary Lesions ◽  
Sirolimus Eluting Stent

Aim : The aim of this study is to compare the 4 years safety and durability of Sirolimus-eluting stent (SES) and Paclitaxel-eluting stent (PES) deployment on the outcome of patients with very long coronary lesions (VLL). Methods : A prospective analysis of 656 patients 730 lesions (male 70.4%, mean age 66.9 yrs) with very long coronary lesion (≥40mm) (368 SES and 288 PES) in five high volume Asian centers after successful stenting in VLL was performed. Lesion locations of VLL were LAD 48.2% (SES 50.2%, PES 45.7%), LCX 18.5%, RCA 33.3%. Complete clinical follow-up to 4 years is being analyzed for all patients. Results : The baseline clinical characteristics between 2 groups were similar. At 4 years overall cardiac events of SES (16.3%) were lower than PES (24.0%) (p=0.03). See table for clinical results. Conclusion : The use of SES and PES in patients with very long coronary lesion was safe and feasible with low acute complication and low incidence of restenosis. SES showed lesser incidence of cardiac events (death, myocardial infarction, CABG and PCI) at 4 years clinical follow-up. SAT (sub acute stent thrombosis), LAST (late stent thrombosis: ~1year), VLAST (very late stent thrombosis: 1year~ 4years) MACE (death, myocardial infarction, CABG and PCI).

scholarly journals Life-Threatening Coronary Artery Spasm Following Sirolimus-Eluting Stent Deployment

2006 ◽  
Vol 47 (9) ◽  
pp. 1911-1912 ◽  
Author(s):  
Stephen Wheatcroft ◽  
Jonathan Byrne ◽  
Martyn Thomas ◽  
Philip MacCarthy
Keyword(s):  
Coronary Artery ◽  
Coronary Artery Spasm ◽  
Stent Deployment ◽  
Life Threatening ◽  
Sirolimus Eluting Stent

Outcomes of a novel thin-strut bioresorbable-polymer sirolimus-eluting stent in patients with chronic total occlusions: A multicenter registry

2018 ◽  
Vol 258 ◽  
pp. 36-41 ◽  
Author(s):  
Lorenzo Azzalini ◽  
Ozan M. Demir ◽  
Gabriele L. Gasparini ◽  
Luca Grancini ◽  
Alessio La Manna ◽  
...  
Keyword(s):  
Chronic Total Occlusions ◽  
Bioresorbable Polymer ◽  
Sirolimus Eluting Stent ◽  
Multicenter Registry

scholarly journals Angiographic Analysis of Trans-Radial Percutaneous Coronary Intervention Cases by the Backup Support of Guide Extension Catheter

2018 ◽  
Vol 33 (1) ◽  
pp. 54-60
Author(s):  
Sahela Nasrin ◽  
Fathima Aaysha Cader ◽  
M Maksumul Haq ◽  
M Liaquat Ali
Keyword(s):  
Coronary Intervention ◽  
Stent Deployment ◽  
Guide Catheter ◽  
Percutaneous Coronary ◽  
Obtuse Marginal Branch ◽  
Type C ◽  
Coronary Lesions ◽  
Obtuse Marginal ◽  
Percutaneous Revascularization ◽  
Diffuse Lesion

Background:The guide extension catheter – Guidezilla (Boston Scientific, United States of America) is a useful adjunctive tool in percutaneous revascularization of complex coronary lesions, and provides an extension to the guide catheter with better coaxial alignment, support and stability.Objective: The objective of this study was to describe the usefulness and easy deliverability of stent by Guidezillain the trans-radial treatment of complex coronary lesions as our initial experience.Methods:This prospective observational study was conducted at the Department of Cardiology, Ibrahim Cardiac Hospital & Research Institute (ICHRI), Dhaka from July 2016 to September 2017. The transradial approach was used in all cases. Clinical, angiographic and procedural data of percutaneous coronary interventions performed using Guidezilla, including indications for use of Guidezilla were collected and analyzed.Results:A total of 19 procedures (in 18 patients) were evaluated. 57.89% of cases were related to left circumflex coronary artery or obtuse marginal branch. The commonest challenge for use of Guidezillawas proximal angulation (63.15%) and calcification (47.4%). Commonest type of lesion was ACC/ AHA Type C lesion (63.2%). Successful stent deployment was achieved in 16 of the 19 procedures (84.2%). Among the unsuccessful cases, there was stent damage in one case and distal dissection after deployment of a stent in other. Stent deployment was not possible in two cases, due to diffuse lesion and heavy calcification.Conclusions:Guide extension catheter is a good trans-radial back-up support for calcified, complex and tortuous coronary anatomy, which otherwise may have been considered unsuitable for PCI. The use of such support can reduce the necessity for the more expensive alternative of deploying multiple small stents in order to traverse the lesions.Bangladesh Heart Journal 2018; 33(1) : 54-60

scholarly journals Long-Term Follow-Up of Incomplete Stent Apposition in Patients Who Received Sirolimus-Eluting Stent for De Novo Coronary Lesions

Circulation ◽  
2003 ◽  
Vol 108 (22) ◽  
pp. 2747-2750 ◽  
Author(s):  
Muzaffer Degertekin ◽  
Patrick W. Serruys ◽  
Kengo Tanabe ◽  
Chi Hang Lee ◽  
J. Edouardo Sousa ◽  
...  
Keyword(s):  
De Novo ◽  
Incomplete Stent Apposition ◽  
Long Term Follow Up ◽  
Coronary Lesions ◽  
Sirolimus Eluting Stent

scholarly journals Very long sirolimus-eluting stent implantation for de novo coronary lesions

2004 ◽  
Vol 93 (7) ◽  
pp. 826-829 ◽  
Author(s):  
Muzaffer Degertekin ◽  
Chourmouzios A Arampatzis ◽  
Pedro A Lemos ◽  
Francesco Saia ◽  
Angela Hoye ◽  
...  
Keyword(s):  
Stent Implantation ◽  
De Novo ◽  
Coronary Lesions ◽  
Sirolimus Eluting Stent
Sign in / Sign up

Export Citation Format

Share Document